Edition:
United Kingdom

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

43.90EUR
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
€43.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,745,140
52-wk High
€69.90
52-wk Low
€38.28

Summary

Name Age Since Current Position

Gerd Krick

80 2003 Independent Chairman of the Supervisory Board

Stephan Sturm

56 2017 Chairman of the Management Board, Chief Executive Officer

Michael Diekmann

64 Independent Deputy Chairman of the Supervisory Board

Niko Stumpfoegger

63 2008 Independent Deputy Chairman of the Supervisory Board

Dieter Schenk

66 2007 Deputy Chairman of the Supervisory Board and Lawyer and Tax Consultant

Rachel Empey

43 2017 Chief Financial Officer, Member of the Management Board

Juergen Goetz

55 2007 Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management Board

Francesco De Meo

56 2008 Member of the Management Board, Chief Executive Officer of Business Segment Fresenius Helios

Mats Henriksson

52 2013 Member of the Management Board, Chief Executive Officer of Business Segment Fresenius Kabi

Rice Powell

64 2013 Member of the Management Board, Chief Executive Officer of Business Segment Fresenius Medical Care

Ernst Wastler

61 2008 Member of the Management Board, Chief Executive Officer of Business Segment Fresenius Vamed

D. Michael Albrecht

69 2010 Independent Member of the Supervisory Board

Bernd Behlert

60 2018 Independent Member of the Supervisory Board

Oscar de Paco

45 2016 Independent Member of the Supervisory Board

Konrad Koelbl

59 2007 Independent Member of the Supervisory Board

Stefanie Lang

50 2016 Independent Member of the Supervisory Board

Frauke Lehmann

56 2016 Independent Member of the Supervisory Board

Iris Loew-Friedrich

58 2016 Independent Member of the Supervisory Board

Klaus-Peter Mueller

74 2008 Independent Member of the Supervisory Board

Hauke Stars

52 2016 Independent Member of the Supervisory Board

Markus Georgi

2015 Senior Vice President Investor Relations

Biographies

Name Description

Gerd Krick

Dr. Gerd Krick is Independent Chairman of the Supervisory Board of Fresenius SE & Co. KGaA since May 28, 2003. In addition, he acts as Chairman of the Nomination Committee, as well as Member of the Audit Committee of the Company and Member of the Joint Committee. He is former Chairman of the Management Board of Fresenius AG. Dr. Krick is also Chairman of the Supervisory Board of Fresenius Management SE, Fresenius Medical Care AG & Co. KGaA and VAMED AG. He is also Member of the Supervisory Board of Fresenius Medical Care Management AG.

Stephan Sturm

Mr. Stephan Sturm is Chief Executive Officer and Chairman of the Management Board at Fresenius SE & Co. KGaA since July 1, 2016. He was also Chief Financial Officer of the Company from January 1, 2005 till July 31, 2017 and Member of the Management Board at the Company from January 1, 2005 to June 30, 2016. Prior to that, he was Managing Director of Credit Suisse First Boston (CSFB), from 2000 as Head of Investment Banking for Germany and Austria, and also served on CSFB's European Management Committee. During his more than thirteen years in investment banking, he held various executive positions with BHF-Bank, Union Bank of Switzerland and CSFB in Frankfurt and London. Prior to entering investment banking in 1991, he was Management Consultant at McKinsey & Co in Duesseldorf and Frankfurt. Currently, he serves as Chairman of the Supervisory Boards of Fresenius Kabi AG and Fresenius Medical Care Management AG as well as Deputy Chairman of the Supervisory Board of VAMED AG. He is also Member of the Supervisory Board of Deutsche Lufthansa AG. He holds a degree in Business from Universitaet Mannheim.

Michael Diekmann

Mr. Michael Diekmann is Independent Deputy Chairman of the Supervisory Board at Fresenius SE & Co. KGaA. He has been Member of the Supervisory Board at the Company since May 20, 2015. He is Member of the Nomination and Joint Committees. He holds a degree in Bachelor of Arts in Philosophy from Georg-August-Universitaet Goettingen. He also holds a law degree from the Georg-August-Universitaet Goettingen. He serves as Chairman of the Supervisory Board of Allianz SE since May 7, 2017, Deputy Chairman of the Supervisory Board of BASF SE, at Linde AG (until May 10, 2017, Second Deputy Chairman) and Member of the Supervisory Board of Siemens AG.

Niko Stumpfoegger

Mr. Niko Stumpfoegger is Independent Deputy Chairman of the Supervisory Board of Fresenius SE & Co. KGaA since May 21, 2008 and has been on the Supervisory Board since July 16, 2007. In addition, he acts as Secretary of the Trade Union ver.di, Head of Company and Industry Politics in health Care and Social Affairs.

Dieter Schenk

Dr. Dieter Schenk is Deputy Chairman of the Supervisory Board and Lawyer and Tax Consultant of the Company. In addition, he also acted as Member of the Nomination Committee of the Company as of October 16, 2007. Until 2007, Dr. Schenk was active as Company's Member of the Supervisory Board. He is Lawyer and Tax Consultant. In addition to his positions at the Company, Dr. Schenk served on Supervisory Board of several companies, including Fresenius Medical Care AG & Co KGaA (Deputy Chairman), Fresenius Medical Care Management AG (Deputy Chairman), Gabor Schoes AG (Chairman), Greiffenberger AG (Deputy Chairman) and TOPTICA Photonics AG (Chairman). Moreover, he was Chairman of the Administrative Board of Else Kroener-Fresenius-Stiftung.

Rachel Empey

Ms. Rachel Clare Empey is Chief Financial Officer and Member of the Management Board at Fresenius SE & Co. KGaA since August 1, 2017. She is also Deputy Chair of the Supervisory Board of Fresenius Kabi AG since October 1, 2017 and Member of the Supervisory Board of Fresenius Medical Care Management AG since September 1, 2017. She serves as Non-Executive Director of Inchcape plc.

Juergen Goetz

Dr. Juergen Goetz is Chief Legal and Compliance Officer, Labor Relations Director, as well as Member of the Management Board of Fresenius SE & Co KGaA since July 1, 2007. From April 1, 2005 until his appointment to the Management Board, Dr. Goetz led the Legal and Insurance Department of Fresenius AG as Senior Vice President and General Counsel. He began his career in 1993 at Hoechst AG, where he held several senior management positions. In 1997, he became head of the Legal Department of Hoechst Marion Roussel AG. In 1999, Dr. Goetz took over the Legal - Global Corporate department of Aventis Pharma AG, the successor company to Hoechst Marion Roussel.

Francesco De Meo

Dr. Francesco De Meo is Member of the Management Board and Chief Executive Officer of Business Segment Fresenius Helios at Fresenius SE & Co KGaA since January 1, 2008. In 2000, Dr. De Meo became head of the legal and human resources departments of HELIOS Kliniken GmbH. On January 1, 2001, he was appointed to the HELIOS Kliniken Management Board with responsibilities for human resources, legal affairs, research and science. At the same time, he was also appointed Labor Relations Director. Before joining HELIOS, he was Director of Rauser AG, a management consultancy in Reutlingen, as well as a practicing Attorney. Currently, he serves as Chairman of the Supervisory Boards of Helios Beteiligungs AG and Helios Kliniken Schwerin GmbH. He studied Law and earned a Doctorate degree at Eberhard Karls Universitaet Tuebingen.

Mats Henriksson

Mr. Mats Christer Henriksson is Member of the Management Board and Chief Executive Officer of Business Segment Fresenius Kabi at Fresenius SE & Co KGaA since January 1, 2013. He joined the Management Board of Fresenius Kabi on September 1, 1999 and served as President of the region Asia Pacific from 2001 until February 2012. Since March 1, 2012 he had been Deputy Chairman of the Management Board of Fresenius Kabi AG and was appointed as CEO effective as of January 1, 2013. Prior to joining the Fresenius Group, Mats Henriksson held several management positions in controlling and finance at Pharmacia. He is Chairman of the Supervisory Board of Fresenius Kabi Austria GmbH, Member of the supervisory Boards of Fresenius Kabi Espana S.A.U. and Labesfal – Laboratorios Almiro, S.A. He is also Chairman of the Administrative Board of Fresenius Kabi Italia S.p.A., and Member of the Boards of Directors of Fenwal, Inc. and FHC (Holdings) Ltd., among others. Mats Henriksson holds a Bachelor of Science degree in Business Administration and Economics from Gothenburg School of Economics in Sweden.

Rice Powell

Mr. Rice Powell is Member of the Management Board, Chief Executive Officer of Business Segment Fresenius Medical Care at Fresenius SE & Co KGaA since January 1, 2013. He joined Fresenius Medical Care in 1997 and was appointed to the Company's Management Board and Co-CEO of Fresenius Medical Care North America in January 2004. In 2010, he was assumed the position of Vice Chairman of the Management Board and Member of the Management Board responsible for the region North America. He has over 30 years of experience in the healthcare industry. From 1978 to 1996 he held various positions, among others at Baxter International Inc. and Biogen Inc in the U.S. He is Vice Chairman of the Administrative Board of Vifor Fresenius Medical Care Renal Pharma Ltd. and Chairman of the Board of Directors of Fresenius Medical Care Holdings, Inc.

Ernst Wastler

Dr. Ernst Wastler is Member of the Management Board and Chief Executive Officer of Business segment Fresenius Vamed at Fresenius SE & Co KGaA since January 1, 2008. Dr. Wastler became Member of the VAMED AG Management Board in 1998 and was responsible for projects and services central Europe. Prior to that, he held several management positions at international business segments of the VAMED Group. His career began in 1981 in international consulting, engineering and project management at Austroplan GmbH in Vienna. Currently, he serves as Deputy Chairman of the Supervisory Board of Charite CFM Facility Management GmbH, as well as Chairman of the Supervisory Board of VAMED-KMB Krankenhausmanagement und Betriebsfuehrungges. m.b.H. He studied International Business at Wirtschaftsuniversitaet Wien (Vienna University of Economics and Business Administration) and earned a Doctorate there in 1983.

D. Michael Albrecht

Prof. Dr. D. Michael Albrecht is Independent Member of the Supervisory Board at Fresenius SE & Co KGaA since May 12, 2010. He is Medical Director and Spokesman of the Management Board of the Universitaetsklinikum Carl Gustav Carus Dresden. Currently, he serves on the Supervisory Boards of Universitaetsklinikum Aachen and GOeK Consulting AG.

Bernd Behlert

Mr. Bernd Behlert is Independent Member of the Supervisory Board of the Company. His Professional Experience. since 09/2018. Chairman of the Group Works Council Helios Kliniken GmbH since 2010. Member of the European Works Council of Fresenius SE & Co. KGaA since 2006. Helios Vogtland-Klinikum Full-time Works Council Member (Chairman) 2003 – 2006. Humaine Vogtland-Klinikum 50% Works Council Member (Chairman); 50% Degreed engineer, Department of biomedical engineering 1990 – 2003. Vogtland-Klinikum Plauen Degreed engineer since 1994 Works Council Member (Chairman) 1985 – 1990. Bezirkskrankenhaus Plauen Degreed engineer. Education 1980 – 1985. Ilmenau University of Technology Engineering degree in Technical Cybernetics and Biomedical Engineering.

Oscar de Paco

Mr. Oscar Romero de Paco is Independent Member of the Supervisory Board of Fresenius SE & Co. KGaA since May 13, 2016. He is production staff member. He is also Member of the Works Council of Fresenius Kabi Espana S.A.U. and Member of the European Works Council of the Company.

Konrad Koelbl

Mr. Konrad Koelbl is Independent Member of the Supervisory Board of Fresenius SE & Co KGaA since July 16, 2007. In addition, he acts as Member of the Audit Committee of the Company as of September 15, 2007. He serves as Member of the Manual Workers' Works Council at VAMED-KMB Krankenhausmanagement und Betriebsfuehrungsges. m.b.H. and Chairman of the Group Works Council VAMED AG. He is also Member of the European Works Council of the Company, Member of the Supervisory Board of VAMED-KMB Krankenhausmanagement und Betriebsfuehrungsges. m.b.H.

Stefanie Lang

Ms. Stefanie Lang is Independent Member of the Supervisory Board of Fresenius SE & Co. KGaA since May 13, 2016. She is Chairman of the Works Council of Fresenius Medical Care Deutschland GmbH.

Frauke Lehmann

Ms. Frauke Lehmann is Independent Member of the Supervisory Board at Fresenius SE & Co. KGaA since May 13, 2016. She is Chair of the Works Council of Helios Kliniken Schwerin GmbH, Member of the Group Works Council of Helios Kliniken GmbH and Member of the European Works Council of the Company. She is also Deputy Chairman of the Supervisory Board of Helios Kliniken Schwerin GmbH.

Iris Loew-Friedrich

Prof. Dr. Iris Loew-Friedrich is Independent Member of the Supervisory Board of Fresenius SE & Co. KGaA since May 13, 2016. She is Chief Medical Officer and Executive Vice President, Head of Development and Medical Patient Value Practices at UCB S.A. She is also Member of the Supervisory Board of Evotec AG.

Klaus-Peter Mueller

Mr. Klaus-Peter Mueller is Independent Member of the Supervisory Board at Fresenius SE & Co KGaA since May 21, 2008. He has been Chairman of the Supervisory Board of Commerzbank AG since May 15, 2008. In addition, he serves as Member of the Supervisory Board of Fresenius Management SE. Moreover, Mr. Mueller is Member of the Board of Directors of Parker Hannifin Corporation. He is Chairman of the Audit Committee and Member of the Nomination Committee of the Company.

Hauke Stars

Ms. Hauke Stars is Independent Member of the Supervisory Board of Fresenius SE & Co. KGaA since May 13, 2016. She is Member of the Executive Board of Deutsche Boerse AG. She is also Member of the Supervisory Boards of Clearstream International S.A. (since May 3, 2017, Deutsche Boerse AG Group mandate) and Eurex Frankfurt AG (Deutsche Boerse AG Group mandate), as well as Member of the Administrative Board of Eurex Zuerich AG (Deutsche Boerse AG Group mandate) and Kuehne + Nagel International AG. She is Member of the Audit Committee of the Company.

Markus Georgi

Basic Compensation